Exablate Neuro is an ultrasound device intended to treat essential tremor in patients who do not respond to conventional medication.
Siemans’ MR imaging technology will provide patient-specific treatment planning and continuous temperature monitoring to allow clinicians to assess treatment outcomes in real-time during Exablate Neuro procedures.
“Our agreement with Siemens Healthineers will allow us to significantly expand Exablate Neuro’s market presence. Siemens has embraced our technology and together we will bring our therapy to significantly more patients and providers,” said Maurice R. Ferré, MD, Insightec’s CEO and chairman of the board.
More articles on supply chain:
Zimmer Biomet acquires CD Diagnostics
Owner of medical supply company sentenced for $3.3M Medicare fraud scheme
Medline, Community Health Ventures enter group purchasing partnership
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
